A detailed history of Zions Bancorporation, N.A. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 2 shares of BIO stock, worth $685. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 3 33.33%
Holding current value
$685
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$268.26 - $339.48 $268 - $339
-1 Reduced 33.33%
2 $0
Q1 2024

May 14, 2024

SELL
$304.11 - $351.99 $304 - $351
-1 Reduced 25.0%
3 $1,000
Q4 2023

Feb 12, 2024

SELL
$269.37 - $365.04 $269 - $365
-1 Reduced 20.0%
4 $1,000
Q3 2023

Nov 07, 2023

SELL
$350.25 - $422.63 $3,852 - $4,648
-11 Reduced 68.75%
5 $1,000
Q2 2023

Jul 28, 2023

SELL
$359.49 - $486.4 $2,875 - $3,891
-8 Reduced 33.33%
16 $6,000
Q4 2022

Feb 10, 2023

BUY
$351.71 - $456.01 $8,089 - $10,488
23 Added 2300.0%
24 $10,000
Q3 2022

Nov 08, 2022

SELL
$412.59 - $563.26 $412 - $563
-1 Reduced 50.0%
1 $0
Q2 2022

Aug 05, 2022

SELL
$463.67 - $597.16 $6,491 - $8,360
-14 Reduced 87.5%
2 $1,000
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $5,770 - $8,089
11 Added 220.0%
16 $9,000
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $708 - $794
1 Added 25.0%
5 $4,000
Q3 2021

Nov 10, 2021

SELL
$657.71 - $825.77 $657 - $825
-1 Reduced 20.0%
4 $3,000
Q2 2021

Aug 11, 2021

SELL
$576.64 - $649.04 $576 - $649
-1 Reduced 16.67%
5 $3,000
Q1 2021

May 13, 2021

BUY
$547.01 - $662.35 $3,282 - $3,974
6 New
6 $3,000
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $5,106 - $6,434
-10 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $4,544 - $5,356
10 New
10 $5,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.44B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.